Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 213

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 213
---
, or disease outbreaks (including the COVID-19 virus)/ public health emergencies (as declared by the World 
 Health Organization or the Health and Human Services Secretary of the United States); and                                                  |

| e) | any failure in and of itself by any Longevity Parties to                                                                             
 meet any internal or published budgets, projections, forecasts or predictions of financial performance for any period (provided that 
 the underlying cause of any such failure may be considered in determining whether a Material Adverse Effect has occurred or would    
 reasonably be expected to occur to the extent not excluded from this definition of Material Adverse                                  
 Effect);                                                                                                                             |

In the case of
clauses (a), (b), (c), and (d), such changes may be taken into account to the extent that such changes have had a disproportionate impact
on Longevity Parties, taken as a whole, as compared to other industry participants.

Covenants

Each of the parties
to the Merger Agreement has agreed to (a) use reasonable best efforts to obtain required consents and approvals from any governmental
authority or commercially reasonable efforts in the case of consents from third parties. Each of the parties to the Merger Agreement has
also agreed to cooperate and use its respective commercially reasonable efforts to take or cause to be taken such other actions as may
be necessary to consummate the Business Combination as promptly as practicable, and (b) use commercially reasonable efforts to take such
other action as may reasonably be necessary or as another party may reasonably request to satisfy the conditions of the other party or
otherwise to comply with the Merger Agreement and to consummate the Business Combination as soon as practicable.

Prior to the
Closing, Longevity has agreed to, and agreed to cause its subsidiaries to, except as contemplated or permitted by the Merger Agreement
or the other Ancillary Documents, set forth on the Longevity schedules to the Merger Agreement (the “Longevity Schedules”)
or consented to by FutureTech (which consent shall not be unreasonably conditioned, withheld, delayed or denied), use its commercially
reasonable efforts to operate its business in the ordinary course of business, including complying with and maintaining all material permits
necessary for the lawful conduct of its business.

Longevity has
agreed that, unless otherwise required or permitted under the Merger Agreement, and subject to certain disclosed exceptions, neither Longevity
nor its subsidiaries will take the following actions during the interim period between signing of the Merger Agreement and Closing, among
others,